Pocket Similarity Identifies Selective Estrogen Receptor Modulators As Microtubule Modulators at the Taxane Site

Overview

Journal Nat Commun

Specialty Biology

Date 2019 Mar 6

PMID 30833575

Citations 10

Authors

Yu-Chen Lo

Olga Cormier

Tianyun Liu

Kendall W Nettles

John A Katzenellenbogen

Tim Stearns

Russ B Altman

Affiliations

Soon will be listed here.

Abstract

Taxanes are a family of natural products with a broad spectrum of anticancer activity. This activity is mediated by interaction with the taxane site of beta-tubulin, leading to microtubule stabilization and cell death. Although widely used in the treatment of breast cancer and other malignancies, existing taxane-based therapies including paclitaxel and the second-generation docetaxel are currently limited by severe adverse effects and dose-limiting toxicity. To discover taxane site modulators, we employ a computational binding site similarity screen of > 14,000 drug-like pockets from PDB, revealing an unexpected similarity between the estrogen receptor and the beta-tubulin taxane binding pocket. Evaluation of nine selective estrogen receptor modulators (SERMs) via cellular and biochemical assays confirms taxane site interaction, microtubule stabilization, and cell proliferation inhibition. Our study demonstrates that SERMs can modulate microtubule assembly and raises the possibility of an estrogen receptor-independent mechanism for inhibiting cell proliferation.

Citing Articles

Sex Differences in Taxane Toxicities.

Chmielewski N, Limoli C Cancers (Basel). 2022; 14(14).

PMID: 35884386 PMC: 9317669. DOI: 10.3390/cancers14143325.

Utilization of Photoaffinity Labeling to Investigate Binding of Microtubule Stabilizing Agents to P-Glycoprotein and β-Tubulin.

Huang Yang C, Horwitz S, McDaid H J Nat Prod. 2022; 85(3):720-728.

PMID: 35240035 PMC: 9484556. DOI: 10.1021/acs.jnatprod.2c00106.

Therapeutic opportunities in cancer therapy: targeting the p53-MDM2/MDMX interactions.

Munisamy M, Mukherjee N, Thomas L, Pham A, Shakeri A, Zhao Y Am J Cancer Res. 2022; 11(12):5762-5781.

PMID: 35018225 PMC: 8727821.

A Genome-Edited ERα-HiBiT Fusion Reporter Cell Line for the Identification of ERα Modulators High-Throughput Screening and CETSA.

Larson H, Zakharov A, Sarkar S, Yang S, Rai G, Larner J Assay Drug Dev Technol. 2021; 19(8):539-549.

PMID: 34662221 PMC: 8713567. DOI: 10.1089/adt.2021.059.

Discovery of facile amides-functionalized rhodanine-3-acetic acid derivatives as potential anticancer agents by disrupting microtubule dynamics.

Zhou X, Liu J, Meng J, Fu Y, Wu Z, Ouyang G J Enzyme Inhib Med Chem. 2021; 36(1):1996-2009.

PMID: 34525898 PMC: 8451688. DOI: 10.1080/14756366.2021.1975695.

References

Ashburn T, Thor K . Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov. 2004; 3(8):673-83. DOI: 10.1038/nrd1468. View

Lukinavicius G, Reymond L, DEste E, Masharina A, Gottfert F, Ta H . Fluorogenic probes for live-cell imaging of the cytoskeleton. Nat Methods. 2014; 11(7):731-3. DOI: 10.1038/nmeth.2972. View

Janssen A, Kops G, Medema R . Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells. Proc Natl Acad Sci U S A. 2009; 106(45):19108-13. PMC: 2776415. DOI: 10.1073/pnas.0904343106. View

Jordan M, Toso R, Thrower D, Wilson L . Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci U S A. 1993; 90(20):9552-6. PMC: 47607. DOI: 10.1073/pnas.90.20.9552. View

Xiao H, Verdier-Pinard P, Fernandez-Fuentes N, Burd B, Angeletti R, Fiser A . Insights into the mechanism of microtubule stabilization by Taxol. Proc Natl Acad Sci U S A. 2006; 103(27):10166-10173. PMC: 1502429. DOI: 10.1073/pnas.0603704103. View

Lo Y, Senese S, France B, Gholkar A, Damoiseaux R, Torres J . Computational Cell Cycle Profiling of Cancer Cells for Prioritizing FDA-Approved Drugs with Repurposing Potential. Sci Rep. 2017; 7(1):11261. PMC: 5595967. DOI: 10.1038/s41598-017-11508-2. View

Nwachukwu J, Srinivasan S, Zheng Y, Wang S, Min J, Dong C . Predictive features of ligand-specific signaling through the estrogen receptor. Mol Syst Biol. 2016; 12(4):864. PMC: 4848761. DOI: 10.15252/msb.20156701. View

Yvon A, Wadsworth P, Jordan M . Taxol suppresses dynamics of individual microtubules in living human tumor cells. Mol Biol Cell. 1999; 10(4):947-59. PMC: 25218. DOI: 10.1091/mbc.10.4.947. View

Zasadil L, Andersen K, Yeum D, Rocque G, Wilke L, Tevaarwerk A . Cytotoxicity of paclitaxel in breast cancer is due to chromosome missegregation on multipolar spindles. Sci Transl Med. 2014; 6(229):229ra43. PMC: 4176609. DOI: 10.1126/scitranslmed.3007965. View

10.

Senese S, Lo Y, Huang D, Zangle T, Gholkar A, Robert L . Chemical dissection of the cell cycle: probes for cell biology and anti-cancer drug development. Cell Death Dis. 2014; 5:e1462. PMC: 4237247. DOI: 10.1038/cddis.2014.420. View

11.

Saoudi Y, Fotedar R, Abrieu A, Doree M, Wehland J, Margolis R . Stepwise reconstitution of interphase microtubule dynamics in permeabilized cells and comparison to dynamic mechanisms in intact cells. J Cell Biol. 1998; 142(6):1519-32. PMC: 2141776. DOI: 10.1083/jcb.142.6.1519. View

12.

Cuzick J, Sestak I, Baum M, Buzdar A, Howell A, Dowsett M . Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol. 2010; 11(12):1135-41. DOI: 10.1016/S1470-2045(10)70257-6. View

13.

Muchmore D . Raloxifene: A selective estrogen receptor modulator (SERM) with multiple target system effects. Oncologist. 2000; 5(5):388-92. DOI: 10.1634/theoncologist.5-5-388. View

14.

Ganguly A, Cabral F, Yang H, Patel K . Peloruside A is a microtubule-stabilizing agent with exceptional anti-migratory properties in human endothelial cells. Oncoscience. 2015; 2(6):585-95. PMC: 4506362. DOI: 10.18632/oncoscience.169. View

15.

George O, Bryant B, Chinnasamy R, Corona C, Arterburn J, Shuster C . Bisphenol A directly targets tubulin to disrupt spindle organization in embryonic and somatic cells. ACS Chem Biol. 2008; 3(3):167-79. PMC: 3844426. DOI: 10.1021/cb700210u. View

16.

Kellogg E, Hejab N, Howes S, Northcote P, Miller J, Fernando Diaz J . Insights into the Distinct Mechanisms of Action of Taxane and Non-Taxane Microtubule Stabilizers from Cryo-EM Structures. J Mol Biol. 2017; 429(5):633-646. PMC: 5325780. DOI: 10.1016/j.jmb.2017.01.001. View

17.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

18.

Malingre M, Schellens J, van Tellingen O, Ouwehand M, Bardelmeijer H, Rosing H . The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients. Br J Cancer. 2001; 85(10):1472-7. PMC: 2363961. DOI: 10.1054/bjoc.2001.2118. View

19.

Lehmann L, Metzler M . Bisphenol A and its methylated congeners inhibit growth and interfere with microtubules in human fibroblasts in vitro. Chem Biol Interact. 2004; 147(3):273-85. DOI: 10.1016/j.cbi.2004.01.005. View

20.

Huang Yang C, Horwitz S . Taxol: The First Microtubule Stabilizing Agent. Int J Mol Sci. 2017; 18(8). PMC: 5578123. DOI: 10.3390/ijms18081733. View